Subtype
Malignant Urinary System Neoplasm
CI-CAN-00001187Explore in graph →
887 active trials28 approved drugs109 evidence items
- NCIt
- C9297
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001187Explore in graph →
Clinical trials
3,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (556)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00073307 | Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer | completed | Phase 3 | 903 | BayerINDUSTRY | 19 | Feb 6, 2014 | clinicaltrials |
| NCT00387764 | Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer | completed | Phase 3 | 80 | GlaxoSmithKlineINDUSTRY | 20 | Jan 14, 2014 | clinicaltrials |
| NCT00553124 |
| Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer |
| unknown |
| Phase 3 |
| 3,400 |
| University Hospital BirminghamOTHER |
| 1 |
| Jan 10, 2014 |
| clinicaltrials |
| NCT00553345 | Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer | unknown | Phase 3 | 515 | University of BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00053820 | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | completed | Phase 3 | 670 | Medical Research CouncilOTHER_GOV | 4 | Dec 19, 2013 | clinicaltrials |
| NCT00002490 | Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer | completed | Phase 3 | — | Medical Research CouncilOTHER_GOV | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00003814 | Eflornithine in Treating Patients With Bladder Cancer | completed | Phase 3 | 450 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00024349 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | completed | Phase 3 | 350 | University Hospital BirminghamOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00054626 | Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer | unknown | Phase 3 | 700 | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, ItalyOTHER_GOV | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00474786 | Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib(INTORSECT) | completed | Phase 3 | 512 | PfizerINDUSTRY | 20 | Nov 21, 2013 | clinicaltrials |
| NCT00003725 | Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer | unknown | Phase 3 | 300 | Anthra PharmaceuticalsINDUSTRY | 2 | Nov 6, 2013 | clinicaltrials |
| NCT00052637 | Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer | completed | Phase 3 | — | PhotocureINDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
| NCT00233402 | Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy | completed | Phase 3 | 789 | PhotocureINDUSTRY | 5 | Oct 11, 2013 | clinicaltrials |
| NCT00412971 | A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer | completed | Phase 3 | 233 | PhotocureINDUSTRY | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00033436 | Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer | completed | Phase 3 | 330 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00492258 | Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer | completed | Phase 3 | 1,656 | Medical Research CouncilOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01094964 | Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer | unknown | Phase 3 | 242 | Cancer Research Campaign Clinical Trials CentreOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00502034 | Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. | completed | Phase 3 | 310 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00018941 | Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 3 | — | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00002473 | Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00002990 | Surgery and BCG in Treating Patients With Bladder Cancer | completed | Phase 3 | 1,288 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT00014274 | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium | completed | Phase 2 / Phase 3 | 238 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jun 12, 2013 | clinicaltrials |
| NCT00022191 | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer | completed | Phase 3 | 608 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 16 | Jun 12, 2013 | clinicaltrials |
| NCT00006034 | Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer | completed | Phase 3 | — | IntracelINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT00005995 | AE-941 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 3 | — | AEterna ZentarisINDUSTRY | 1 | Mar 5, 2013 | clinicaltrials |
| NCT01481870 | Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma(CROSS-J-RCC) | unknown | Phase 3 | 120 | Yamagata UniversityOTHER | 1 | Feb 25, 2013 | clinicaltrials |
| NCT00006124 | Celecoxib in Treating Patients With Bladder Cancer | completed | Phase 2 / Phase 3 | 152 | National Cancer Institute (NCI)NIH | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00410124 | RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib(RECORD-1) | completed | Phase 3 | 416 | Novartis PharmaceuticalsINDUSTRY | 10 | Jan 15, 2013 | clinicaltrials |
| NCT01734798 | Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer | completed | Phase 3 | 198 | Cairo UniversityOTHER | 1 | Nov 28, 2012 | clinicaltrials |
| NCT00065468 | Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma(ARCC) | completed | Phase 3 | 626 | PfizerINDUSTRY | 25 | Oct 25, 2012 | clinicaltrials |
| NCT00416429 | Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer | completed | Phase 3 | 456 | Centre Leon BerardOTHER | 0 | Sep 26, 2012 | clinicaltrials |
| NCT00416871 | Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer | completed | Phase 3 | 220 | Centre Leon BerardOTHER | 0 | Sep 26, 2012 | clinicaltrials |
| NCT00042887 | Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer | terminated | Phase 3 | 58 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | completed | Phase 3 | 96 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00033904 | Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer | completed | Phase 3 | 650 | Agenus Inc.INDUSTRY | 11 | Sep 7, 2012 | clinicaltrials |
| NCT00126178 | Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer | terminated | Phase 3 | 600 | Agenus Inc.INDUSTRY | 2 | Sep 7, 2012 | clinicaltrials |
| NCT00002737 | Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer | completed | Phase 3 | 320 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00002764 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | completed | Phase 3 | 340 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00237575 | Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer | terminated | Phase 3 | 100 | University of KentuckyOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT01542567 | Efficacy of Diclofenac BCG Irrigations(DIC-2011) | unknown | Phase 3 | 100 | Carmel Medical CenterOTHER | 0 | May 22, 2012 | clinicaltrials |
| NCT00311467 | Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma | terminated | Phase 3 | 172 | Central European Cooperative Oncology GroupOTHER | 1 | May 16, 2012 | clinicaltrials |
| NCT00003824 | S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer | terminated | Phase 3 | 114 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00622973 | USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases | completed | Phase 3 | 130 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT01149174 | Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer(EMDA/PRE-TUR) | completed | Phase 3 | 352 | University of Rome Tor VergataOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT01442519 | Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer(BCG/EMDA-MMC) | completed | Phase 3 | 212 | University of Rome Tor VergataOTHER | 1 | Sep 28, 2011 | clinicaltrials |
| NCT00478114 | Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) | completed | Phase 3 | 15 | Mahidol UniversityOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT01087268 | Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer | unknown | Phase 3 | 75 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT01082510 | Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study) | unknown | Phase 3 | 288 | Urological Oncology Council of Northern TokyoOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00330707 | Combined Use of BCG and Interferon Alpha in Bladder Cancer | completed | Phase 2 / Phase 3 | 140 | National University Hospital, SingaporeOTHER | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00083889 | SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma | completed | Phase 3 | 750 | PfizerINDUSTRY | 11 | Jan 26, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Feb 6, 2014source: clinicaltrials